TSK Laboratories

The TSK Group was founded in 1948 by the original founder Yonesaburou Kawashima, who later received the prestigious “Order of the Rising Sun” from emperor Akihito in 2011 for significant achievement and contribution to the nation for his work in the medical field.

His son Yukio Kawashima started TSK Laboratory, Japan in 1974. Shortly after founding his new company Mr Kawashima launched a very special kind of Biopsy needle, called SURECUT, invented by Mr. Yukio Kawashima. SURECUT was unique and offered physicians and the pathologists working with them a new tool in diagnosing Cancer and other diseases.

This meant more accurate diagnosis, better treatment, and lives saved. SURECUT became a market leading biopsy needle and over time was copied by many companies. Millions and Millions of these biopsy needles have been sold all over the world.

In the early 80’s TSK Laboratory introduced a new two-stage histological biopsy device called ACECUT. The advantages of that product have also improved diagnosis, and thereby allowing the appropriate treatment, which again, has saved millions of lives around the world.

Throughout the 1980-1990 TSK Laboratory several new needle innovations would be added the line of medical devices. The first international office was openend in Vancouver Canada by Mr Kawashima’s son in law Mr Shane Johnson. After TSK Laboratory Europe was established in 2010, TSK began producing needle products for the Aesthetics market.

In the years that we have been producing these products, TSK Laboratory has improved the lives of hundreds of millions of people around the world. Over the past two decades, TSK Laboratory went through several manufacturer plant expansion plans. Again bringing forward industry leading needle innovations. Innovations that allow people to feel better, look better, with less pain, and put simply- improve their lives.

In 2019 the company celebrated its 45th Anniversary, the achievements and retirement of Mr. Yukio Kawashima, and the beginning of a new Era at TSK under the leadership of Mr. Ken Kawashima. We currently have three different production sites in Japan, global offices in Japan, Canada, The Netherlands, China and soon to be expected in the USA and Australia.

At our facilities, we dedicate ourselves to apply the highest quality standards, from product development to production, in order to ensure the safety of every patient that is being treated with our products. All facilities and ISO certified cleanrooms pass the highest level of inspection and auditing standards, incorporated by major overseas pharmaceutical companies, medical companies and authorities.

No products were found matching your selection.

Main Menu